CANCER DRIVER INTERCEPTION, Systemic Inflammation, Gut Dysbiosis, Genomic Instability, Immune System Deficiency, PRENATAL SCREENING, G-TEST, ULTRANIPT , ULTRANIPT DG, OMNIPT, Inherited Metabolic Disorder, Severe Combined Immunodeficiency, Lysosomal Storage Diseases, CANCER EARLY DETECTION, Solid Cancer, Breast and Ovary, Lung, Colon and rectum, Genome Instability, AESTHETICS STEM CELLS, Skin Rejuvenation, Face Reshaping, Breast augmentation, Buttock enhancement, Scar Reduction, Hair Loss, Female rejuvenation, Penis enlargment, HEREDITARY CANCERS DRIVERS, Endometrium, Colon, Solid Cancers, Breast and Ovary, REGENERATIVE STEM CELLS, Orthopedics, Premature Ovarian Failure, Erectile dysfunction, Anti-aging Therapy iV, Empty Nose Syndrome, Body Performance, Supportive Care, CANCER DIAGNOSIS, Colon and Rectum, Breast, Ovary and Prostate, Lung Cancer Assay, Liquid Biopsy, STEM CELL EXOSOMES, Skin Aging, Hair Loss, Orthopedics, Erectile Dysfunction, Female Rejuvenation, Body Performance, Anti-Ageing, PREVENTIVE CANCER THERAPY, Systemic Inflammation, Dysbiosis, Genomic Instability, Immune Deficiency, STEM CELL BANKING, Cord Blood Derived, Cord Tissue Derived, Adipose Tissue Derived, EXOSOME COSMETICS, X-FILL – Eye & Lip Contour, X-LIFT – Firm Facial Lifting, X-SKIN- Advanced Moisturizing, X-HAIR – Hair Loss Treatment
Skip to main content

Prenatal Screening

Early assessment of the risk of fetal chromosomal abnormalities

Prenatal Screening

With the next generation of non-invasive prenatal screening, Bioscience Institute provides future parents with the most advanced technologies to assess the health of their babies early and without any risk, from the first weeks of gestation.
A team of qualified professionals will support parents in making thoughtful and informed choices.

G-Test

G-Test® is a non-invasive prenatal screening test for the early assessment of the risk that the fetus may be affected by a chromosomal abnormality. It has 6 analysis options (2 of which are for twin pregnancies) and boasts high accuracy.

Learn more

UltraNIPT 110

ULTRANIPT110 is an expanded non-invasive prenatal screening test. It enables the detection of up to 110 chromosomal anomalies associated with a known syndrome. It has high accuracy and provides the clinical interpretation of any abnormalities detected

Learn more

ULTRANIPT DG

ULTRANIPT DG is a non-invasive prenatal screening test capable of detecting the most common trisomies, DiGeorge Syndrome and DiGeorge Syndrome type 2. The test has high accuracy and provides clinical interpretation of any abnormalities detected.

Learn more

OMNIPT

OMNIPT is an expanded non-invasive prenatal test that allows the detection of 137 genetic diseases, both chromosomal and monogenic, not linked to a hereditary transmission. It has high accuracy and provides the clinical interpretation of any abnormalities detected.

Learn more
×

Information Request








    Privacy Policy (*)